Effects of NMDA receptor antagonists and antipsychotics on high frequency oscillations recorded in the nucleus accumbens of freely moving mice

Psychopharmacology

Volumn 232, Issue 24, 2015, Pages 4525-4535

  Hunt, Mark J ^a,b   Olszewski, Maciej ^a   Piasecka, Joanna ^a   Whittington, Miles A ^b   Kasicki, Stefan ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Antipsychotics; Mice; NMDA receptor antagonists; Oscillations; Schizophrenia

Indexed keywords

CLOZAPINE; DIZOCILPINE; HALOPERIDOL; HISTAMINE H3 RECEPTOR; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 7 RECEPTOR; AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE MALEATE; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; ELECTRIC POTENTIAL; ENZYME ACTIVATION; HIGH FREQUENCY OSCILLATION; LOCAL FIELD POTENTIAL; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; WISTAR RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HALOPERIDOL; KETAMINE; MALE; MICE; NUCLEUS ACCUMBENS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84947216533     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-015-4073-0     Document Type: Article

References (59)

1. Balu DT, Coyle JT (2015) The NMDA receptor 'glycine modulatory site' in schizophrenia: d-serine, glycine, and beyond. Curr Opin Pharmacol 20C:109-115
2. Berke JD (2011) Functional properties of striatal fast-spiking interneurons. Front Syst Neurosci 5:45
3. Black MD, Varty GB, Arad M, Barak S, De Levie A, Boulay D, Pichat P, Griebel G, Weiner I (2009) Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology 202:385-396
4. Bothe GW, Bolivar VJ, Vedder MJ, Geistfeld JG (2005) Behavioral differences among fourteen inbred mouse strains commonly used as disease models. Comp Med 55:326-334
5. Boulay D, Pichat P, Dargazanli G, Estenne-Bouhtou G, Terranova JP, Rogacki N, Stemmelin J, Coste A, Lanneau C, Desvignes C, Cohen C, Alonso R, Vige X, Biton B, Steinberg R, Sevrin M, Oury-Donat F, George P, Bergis O, Griebel G, Avenet P, Scatton B (2008) Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia. Pharmacol Biochem Behav 91:47-58
6. Brabant C, Charlier Y, Tirelli E (2013) The histamine H(3)-receptor inverse agonist pitolisant improves fear memory in mice. Behav Brain Res 243:199-204
7. Bradford AM, Savage KM, Jones DN, Kalinichev M (2010) Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics. Psychopharmacology 212:155-170
8. Canton H, Verriele L, Millan MJ (1994) Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics. Neurosci Lett 181:65-68
9. Ceglia I, Carli M, Baviera M, Renoldi G, Calcagno E, Invernizzi RW (2004) The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC. J Neurochem 91:189-199
10. Celada P, Bortolozzi A, Artigas F (2013) Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research. CNS Drugs 27:703-716
11. Depoortere R, Dargazanli G, Estenne-Bouhtou G, Coste A, Lanneau C, Desvignes C, Poncelet M, Heaulme M, Santucci V, Decobert M, Cudennec A, Voltz C, Boulay D, Terranova JP, Stemmelin J, Roger P, Marabout B, Sevrin M, Vige X, Biton B, Steinberg R, Francon D, Alonso R, Avenet P, Oury-Donat F, Perrault G, Griebel G, George P, Soubrie P, Scatton B (2005) Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 30:1963-1985
12. Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79-84
13. Grace AA (2000) Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev 31:330-341
14. Groenewegen HJ, Wright CI, Beijer AV, Voorn P (1999) Convergence and segregation of ventral striatal inputs and outputs. Ann N Y Acad Sci 877:49-63
15. Higgins GA, Enderlin M, Haman M, Fletcher PJ (2003) The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism. Psychopharmacology 170:309-319
16. Hiyoshi T, Kambe D, Karasawa J, Chaki S (2014) Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms. Neuropharmacology 85:384-396
17. Holmes A, Wrenn CC, Harris AP, Thayer KE, Crawley JN (2002) Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav 1:55-69
18. Homayoun H, Moghaddam B (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci: Off J Soc Neurosci 27:11496-11500
19. Horiguchi M, Huang M, Meltzer HY (2011) The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. J Pharmacol Exp Ther 338:605-614
20. Hunt MJ, Falinska M, Kasicki S (2010) Local injection of MK801 modifies oscillatory activity in the nucleus accumbens in awake rats. J Psychopharmacol 24:931-941
21. Hunt MJ, Falinska M, Leski S, Wojcik DK, Kasicki S (2011) Differential effects produced by ketamine on oscillatory activity recorded in the rat hippocampus, dorsal striatum and nucleus accumbens. J Psychopharmacol 25:808-821
22. Hunt MJ, Raynaud B, Garcia R (2006) Ketamine dose-dependently induces high-frequency oscillations in the nucleus accumbens in freely moving rats. Biol Psychiatry 60:1206-1214
23. Ito C (2009) Histamine H3-receptor inverse agonists as novel antipsychotics. Cent Nerv Syst Agents Med Chem 9:132-136
24. Ji B, Wang X, Pinto-Duarte A, Kim M, Caldwell S, Young JW, Behrens MM, Sejnowski TJ, Geyer MA, Zhou X (2013) Prolonged ketamine effects in hypomorphic mice: mimicking phenotypes of schizophrenia. PLoS ONE 8:e66327
25. Karasawa J, Hashimoto K, Chaki S (2008) d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behav Brain Res 186:78-83
26. Kargieman L, Santana N, Mengod G, Celada P, Artigas F (2007) Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine. Proc Natl Acad Sci U S A 104:14843-14848
27. Kocsis B (2012) Differential role of NR2A and NR2B subunits in N-methyl-d-aspartate receptor antagonist-induced aberrant cortical gamma oscillations. Biol Psychiatry 71:987-995
28. Konradsson A, Marcus MM, Hertel P, Svensson TH, Jardemark KE (2006) Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex. Synapse 60:102-108
29. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214
30. Kulikova SP, Tolmacheva EA, Anderson P, Gaudias J, Adams BE, Zheng T, Pinault D (2012) Opposite effects of ketamine and deep brain stimulation on rat thalamocortical information processing. Eur J Neurosci 36:3407-3419
31. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 13:9-19
32. Lazarewicz MT, Ehrlichman RS, Maxwell CR, Gandal MJ, Finkel LH, Siegel SJ (2010) Ketamine modulates theta and gamma oscillations. J Cogn Neurosci 22:1452-1464
33. Le Pen G, Kew J, Alberati D, Borroni E, Heitz MP, Moreau JL (2003) Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: reversal by glycine and a glycine transporter inhibitor. Biol Psychiatry 54:1162-1170
34. Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E, Robert P, Parmentier R, Anaclet C, Lin JS, Burban A, Arrang JM, Schwartz JC (2007) Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 73:1215-1224
35. Ma J, Leung LS (2000) Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine. Behav Brain Res 111:1-11
36. McOmish CE, Lira A, Hanks JB, Gingrich JA (2012) Clozapine-induced locomotor suppression is mediated by 5-HT2A receptors in the forebrain. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 37:2747-2755
37. Meltzer HY (1999) The role of serotonin in antipsychotic drug action. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 21:106S-115S
38. Middleton S, Jalics J, Kispersky T, Lebeau FE, Roopun AK, Kopell NJ, Whittington MA, Cunningham MO (2008) NMDA receptor-dependent switching between different gamma rhythm-generating microcircuits in entorhinal cortex. Proc Natl Acad Sci U S A 105:18572-18577
39. Mirjana C, Baviera M, Invernizzi RW, Balducci C (2004) The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 29:1637-1647
40. Newman-Tancredi A, Kleven MS (2011) Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Psychopharmacology 216:451-473
41. Nicolas MJ, Lopez-Azcarate J, Valencia M, Alegre M, Perez-Alcazar M, Iriarte J, Artieda J (2011) Ketamine-induced oscillations in the motor circuit of the rat basal ganglia. PLoS ONE 6:e21814
42. Nikiforuk A, Kos T, Fijal K, Holuj M, Rafa D, Popik P (2013) Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. PLoS ONE 8:e66695
43. Nilsson M, Carlsson A, Carlsson ML (1997) Glycine and d-serine decrease MK-801-induced hyperactivity in mice. J Neural Transm 104:1195-1205
44. Ninan I, Kulkarni SK (1998) 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion. Eur J Pharmacol 358:111-116
45. Olszewski M, Dolowa W, Matulewicz P, Kasicki S, Hunt MJ (2013a) NMDA receptor antagonist-enhanced high frequency oscillations: are they generated broadly or regionally specific? Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 23:1795-1805
46. Olszewski M, Piasecka J, Goda SA, Kasicki S, Hunt MJ (2013b) Antipsychotic compounds differentially modulate high-frequency oscillations in the rat nucleus accumbens: a comparison of first- and second-generation drugs. Int J Neuropsychopharmacol/Off Sci J Coll Int Neuropsychopharmacol 16:1009-1020
47. Phillips KG, Cotel MC, McCarthy AP, Edgar DM, Tricklebank M, O'Neill MJ, Jones MW, Wafford KA (2012) Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia. Neuropharmacology 62:1359-1370
48. Pinault D (2008) N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol Psychiatry 63:730-735
49. Rodrigues AA, Jansen FP, Leurs R, Timmerman H, Prell GD (1995) Interaction of clozapine with the histamine H3 receptor in rat brain. Br J Pharmacol 114:1523-1524
50. Roopun AK, Cunningham MO, Racca C, Alter K, Traub RD, Whittington MA (2008) Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia. Schizophr Bull 34:962-973
51. Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268:1403-1410
52. Russo SJ, Nestler EJ (2013) The brain reward circuitry in mood disorders. Nat Rev Neurosci 14:609-625
53. Sik A, van Nieuwehuyzen P, Prickaerts J, Blokland A (2003) Performance of different mouse strains in an object recognition task. Behav Brain Res 147:49-54
54. Spencer KM (2011) Baseline gamma power during auditory steady-state stimulation in schizophrenia. Front Hum Neurosci 5:190
55. Troyano-Rodriguez E, Llado-Pelfort L, Santana N, Teruel-Marti V, Celada P, Artigas F (2014) Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain. Biol Psychiatry 76:937-945
56. Uhlhaas PJ, Singer W (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11:100-113
57. Vergara R, Rick C, Hernandez-Lopez S, Laville JA, Guzman JN, Galarraga E, Surmeier DJ, Bargas J (2003) Spontaneous voltage oscillations in striatal projection neurons in a rat corticostriatal slice. J Physiol 553:169-182
58. Wittmann M, Marino MJ, Henze DA, Seabrook GR, Conn PJ (2005) Clozapine potentiation of N-methyl-d-aspartate receptor currents in the nucleus accumbens: role of NR2B and protein kinase A/Src kinases. J Pharmacol Exp Ther 313:594-603
59. Wolf JA, Moyer JT, Lazarewicz MT, Contreras D, Benoit-Marand M, O'Donnell P, Finkel LH (2005) NMDA/AMPA ratio impacts state transitions and entrainment to oscillations in a computational model of the nucleus accumbens medium spiny projection neuron. J Neurosci: Off J Soc Neurosci 25:9080-9095